In partnership with
AIHealthTech Insider: Issue #126
November 2, 20263w2q`
Illustrations in this issue are AI-generated.
Hello,
In one randomized trial, the median time to an autoimmune diagnosis was 43 days with an AI-assisted referral process, compared with 138 days in the control group.
The tool flagged higher-risk patients and offered their doctors expedited specialist evaluations. Clinicians still made the decisions.
This week: how it worked, where chatbot health links lead and what AI delirium alerts can miss.
For education, not medical advice.
☕ Quick question before we dive in 👇
If AI joined your healthcare team, what job would you give it?
👇 Later in this issue: AI helped flag delirium in hospital patients. How often were its alerts right?
🔬 The Big Story
AURA: connecting an autoimmune risk score to specialist care
A positive antinuclear antibody test can raise questions about autoimmune disease. But healthy people can test positive too.
Researchers tested AURA—Autoimmune Risk Assessment—using medical-record information to identify higher-risk patients. An automated notification offered their doctors an expedited rheumatology evaluation.
The randomized trial involved 1,960 patients within Vanderbilt’s health system. Both groups continued receiving standard care. Johns Hopkins reported the findings on November 6.
Why it matters: The researchers tested whether AI changed the path to care, beyond producing a prediction.
The honest part: The results don’t establish that the approach works equally well elsewhere or prevents long-term complications. Further validation is needed.
New here? Join 1,500+ readers getting one carefully sourced AI-healthcare briefing every Monday—written in plain English, without the hype.
🤎 Sponsored
Glass Skin Goals? Meet Your Morning Upgrade
Glass skin is the fall beauty goal: a complexion that looks smooth, plump and luminous. Pique’s Carrara Marine Collagen makes supporting that glow a delicious part of your morning routine.
After 90 days on Carrara, 83% reported smoother skin, 80% reported plumper skin and 86% reported greater skin satisfaction.
Each serving combines Type I marine collagen to support skin radiance with rare Type II collagen, sourced from wild Hokkaido salmon, to support elasticity. Together, they bring skin support into a daily ritual that feels like a treat.
Two scoops blend into morning matcha for a creamy latte, making consistency easy as fall schedules fill up. A warm cup, a quiet moment and nourishment from within become part of the same routine.
For anyone pursuing that luminous glass-skin look through sweater season, Carrara adds a beauty upgrade to a habit they already love.
⚡ Quick Hits
🔸Your chatbot cited a clinic. What is it selling?
Simon Fraser University researchers asked six chatbots questions about stem cells and Alzheimer’s disease, autism and cerebral palsy.
Across 540 queries, 23.4% of linked sources came from for-profit treatment businesses.
The honest part: A commercial source isn’t automatically incorrect. But a citation doesn’t prove a treatment works. The findings concern specific questions and tested chatbot versions.
🔸How Google evaluates health AI
Google’s November 4 framework assesses accuracy, safety and usefulness through benchmark questions, automated assessments and expert review.
The honest part: This describes an evaluation method. It doesn’t establish that tools assessed with it improve patients’ health.
🤎 Sponsored
Eat well without any effort.
Getting the nutrition you deserve doesn’t need to take up all your time. CookUnity delivers fresh dishes handcrafted by award-winning chefs, ready to heat in minutes. Build a custom menu for your entire week, so you can spend your evenings on your terms—not scrubbing pans. Skip, pause, or change your plan size anytime.
🧠 Brain in Brief
AI helped flag delirium—but many alerts were false alarms
A study published November 4 in JAMA Network Open evaluated a delirium-risk model at a second Mount Sinai hospital without retraining it.
Among patients assessed for delirium, the average monthly detection rate rose from 9.23% to 19.59% after deployment.
The honest part: Only about 26% of positive model flags corresponded to delirium. Both hospitals belonged to the same health system. Better detection doesn’t establish better long-term outcomes.
🤎 Sponsored
The Missing Piece in Your Weight Loss Journey
GLP-1s have transformed weight loss. But while you’re celebrating your progress, you may also notice changes to your skin, like volume loss and sagging. OneSkin’s OS-01 BODY MOISTURIZER is built to support skin resilience during GLP-1 use—smoothing skin, strengthening the barrier, and boosting resilience with the OS-01 Peptide™.
🌿 Worth Knowing
In development: a wearable patch for serious illness
An MIT-led team received funding to develop a patch that continuously measures biomarkers associated with heart disease and sepsis.
The planned device would use onboard AI to help interpret the measurements.
The honest part: This November 4 announcement concerns a development project—not an available diagnostic patch. Reliable measurement and clinical usefulness still need to be demonstrated.
One useful question this week
When healthcare AI flags a problem, ask:
“What happened next?”
An earlier appointment, a changed treatment and better health are different outcomes. Look for which one researchers actually measured.
Know someone who enjoys health research without the jargon? Forward this issue.
